Craig Hallum Boosts KORU Medical Systems (NASDAQ:KRMD) Price Target to $5.00

KORU Medical Systems (NASDAQ:KRMD) had its price objective hoisted by stock analysts at Craig Hallum from $4.00 to $5.00 in a research note issued on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Craig Hallum’s price objective indicates a potential upside of 57.73% from the stock’s previous close.

Several other analysts have also recently commented on KRMD. Canaccord Genuity Group raised their target price on KORU Medical Systems from $3.00 to $4.00 and gave the stock a “buy” rating in a research report on Thursday. Piper Sandler raised their price objective on KORU Medical Systems from $3.00 to $3.50 and gave the stock an “overweight” rating in a research report on Thursday. Finally, B. Riley started coverage on KORU Medical Systems in a report on Thursday, July 25th. They issued a “buy” rating and a $4.00 target price on the stock.

KORU Medical Systems Stock Up 2.9 %

Shares of NASDAQ:KRMD opened at $3.17 on Thursday. KORU Medical Systems has a 52 week low of $1.98 and a 52 week high of $3.40. The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.27 and a current ratio of 3.77. The company has a market cap of $145.34 million, a PE ratio of -12.68 and a beta of 0.41. The firm has a 50 day simple moving average of $2.65 and a 200 day simple moving average of $2.47.

Institutional Trading of KORU Medical Systems

A number of institutional investors have recently bought and sold shares of the company. First Light Asset Management LLC increased its position in KORU Medical Systems by 1.1% in the 1st quarter. First Light Asset Management LLC now owns 5,220,990 shares of the company’s stock worth $12,322,000 after purchasing an additional 57,253 shares during the last quarter. Archon Capital Management LLC increased its holdings in KORU Medical Systems by 6.2% in the first quarter. Archon Capital Management LLC now owns 3,951,393 shares of the company’s stock worth $9,325,000 after buying an additional 230,517 shares during the last quarter. Vanguard Group Inc. raised its position in KORU Medical Systems by 2.7% during the first quarter. Vanguard Group Inc. now owns 1,961,764 shares of the company’s stock valued at $4,630,000 after acquiring an additional 51,890 shares in the last quarter. Meros Investment Management LP raised its position in KORU Medical Systems by 20.7% during the second quarter. Meros Investment Management LP now owns 804,380 shares of the company’s stock valued at $2,132,000 after acquiring an additional 137,918 shares in the last quarter. Finally, Lakewood Asset Management LLC lifted its stake in KORU Medical Systems by 13.9% in the second quarter. Lakewood Asset Management LLC now owns 68,225 shares of the company’s stock valued at $181,000 after acquiring an additional 8,300 shares during the last quarter. Institutional investors and hedge funds own 58.60% of the company’s stock.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.